Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

Biotechnology

Healthcare
$7.06 -2.70%

-$0.26 today

Market cap
$618.50M
Beta
2.00
P/E (TTM)
-5.1
EPS (TTM)
-$1.80
52W Low $4.02High $36.26

Volume 1.18M

Average 1.27M

Balance Sheet

Inspect the capital base behind the business.

Assets

$533.43M

FY 2025 · Annual

+18.3% YoY

Liabilities

$54.87M

FY 2025 · Annual

+30.6% YoY

Equity

$478.56M

FY 2025 · Annual

+17.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents13.81M23.7M68.54M139.48M48.3M
Short-term Investments273.44M180.72M193.27M294.61M457.14M
Net Receivables130K319K673K2.12M4.06M
Inventory00000
Other Current Assets01.52M1.68M366K1.59M
Total Current Assets290.69M208.9M266.51M438.47M515.45M
Property, Plant & Equipment (Net)4.72M3.98M3.26M2.06M1.15M
Goodwill00000
Intangible Assets000683K0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets540K2.77M7.17M9.76M16.83M
Total Non-current Assets5.26M6.75M10.43M12.51M17.98M
Total Assets295.95M215.65M276.95M450.98M533.43M
Account Payables23K374K2.7M4.46M9.25M
Short-term Debt0001.17M1.12M
Tax Payables88K68K73K41K0
Deferred Revenue00000
Other Current Liabilities3.96M4.6M5.47M30.31M32.02M
Total Current Liabilities9.02M16.55M21.62M41.76M51.8M
Long-term Debt000069K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00003M
Total Non-current Liabilities2.36M1.55M1.43M257K3.07M
Total Liabilities11.38M18.1M23.05M42.02M54.87M
Common Stock3K3K4K6K8K
Retained Earnings(104.19M)(208.98M)(305.63M)(435.11M)(597.56M)
Accumulated OCI(149K)(1.81M)347K143K621K
Other Stockholders Equity00000
Minority Interest00000
Total Equity284.57M197.55M253.9M408.96M478.56M
Total Debt3.29M2.57M2.42M1.43M1.19M
Net Debt(10.52M)(21.14M)(66.12M)(138.05M)(47.11M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$52.5M
Short-term Investments$452.8M
Receivables$3.4M
Other Current$4.5M
Total Current Assets$513.2M
PP&E (Net)$921.0K
Other Non-current$16.5M
Total Non-current Assets$17.4M
Total Assets$530.6M

Analysis

Selected assets total $530.6M for Latest. The largest visible component is Short-term Investments at $452.8M, about 85.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13D/ASC 13D/A filingOct 16, 2026
8-KCurrent reportOct 15, 2026

How much cash does OLMA have?

Olema Pharmaceuticals, Inc. (OLMA) reported $48.30M in cash and equivalents in fiscal 2025.

How much debt does OLMA carry?

Olema Pharmaceuticals, Inc. (OLMA) reported $1.19M of total debt, with net debt of -$47.11M.